Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Integrated Drug Discovery

Product Image
Product Description

Success in drug discovery depends on a deep understanding of the physiological context of a disease and on the knowledge of the properties that make a molecule into a therapeutically and commercially successful drug.

Our medicinal chemists use synthetic chemistry as a tool to solve problems in biology, pharmacology, and medicine. The experience and creativity of our medicinal chemistry team play a key role in advancing your project and ensuring ultimate success.

Selcia Discovery applies a consultative approach to ensure thorough understanding of the project objectives and deliverable. Key to success is a comprehensive grasp on your requirements and then providing high quality compounds to help you move your project forward.

Our approach can be tailored to the specialist needs of academic institutions and small biotechs where we can be the medicinal chemistry resource supporting you with the following key skills

  • Medicinal chemistry expertise
  • Computational chemistry tools
  • Synthetic excellence ensuring speedy execution of synthesis programmes
  • Patent knowledge
  • In-house biology and in vitro ADME
  • Managing outsourced studies
  • Project management

Product Integrated Drug Discovery
Company Selcia Discovery Services
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Selcia Discovery Services
Fyfield Business & Research Park, Fyfield Road, Ongar, Essex CM5 0GS UK

Tel: +44 (0) 1277 367 000
Fax: +44 (0) 1277 367 099
Email: contact@selcia.com



Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!